Preclinical Validation of ZF-148-2 Nanodrug for Breast Cancer: Antitumor Efficacy, Survival Benefit, and Histopathological Safety in the 4T1 Murine Model

Advances in Nanoparticles

Advances in Nanoparticles

Advances in Nanoparticles

ISSN Print: 2169-0510
ISSN Online: 2169-0529
www.scirp.net/journal/anp
E-mail: [email protected]

Citations

Journals Menu

Guidelines & Policies

"Preclinical Validation of ZF-148-2 Nanodrug for Breast Cancer: Antitumor Efficacy, Survival Benefit, and Histopathological Safety in the 4T1 Murine Model"
written by Zahra Fakhroueian, Marzieh Eghtedardoost, Alireza Massiha, Fereshteh Abbasvandi,
published by Advances in Nanoparticles, Vol.15 No.4, 2026

has been cited by the following article(s):

Google Scholar
CrossRef

No relevant information.

Contact us

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.

Top